首页 正文

Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer

{{output}}
Pancreatic cancer is a lethal malignancy with a 5-year survival rate of only 6%. Surgical resection remains the only cure, yet even after resection the 5-year survival is only 20% due to a high recurrence rate. Thus, a high proportion of patients with this dis... ...